BCMU
VXRT

BlueCrest Capital Management (UK)’s Vaxart VXRT Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,700
Closed -$249K – 721
2014
Q1 		$249K Buy
+3,700
New +$229K 0.01% 444

Other funds holding VXRT

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

BlueCrest Capital Management (UK)'s VXRT Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of Vaxart (VXRT) in Q2 2014, closing a stake of 3,700 shares — an estimated $249K sold.

BlueCrest Capital Management (UK) first reported a position in VXRT in Q1 2014 and held it in 1 quarter. The position peaked at $249K in Q1 2014. 58 funds tracked by Wall St. Rank hold VXRT as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining Vaxart position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 3,700 Vaxart shares in Q2 2014, an estimated $249K.
  • BlueCrest Capital Management (UK) first reported a position in Vaxart in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Vaxart position peaked at $249K in Q1 2014.
  • 58 funds tracked by Wall St. Rank held Vaxart as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.